Pfizer shares jump over 5% on reports of UK authorising its COVID-19 vaccine

After opening with mild gains, shares of Pfizer traded almost flat till 1230 hours but saw a sudden spike after the reports of the vaccine.

December 02, 2020 / 08:54 PM IST
 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Shares of Pfizer jumped over 5 percent in intraday trade on BSE on December 2 after reports emerged that the United Kingdom (UK) had authorised the Pfizer-BioNTech COVID-19 vaccine for use.

Media reports suggested that the UK has become the first country to authorise the Pfizer-BioNTech COVID-19 vaccine for use. Britain on December 2 said that the COVID-19 vaccine will be rolled out for use from next week.

“The Government has today accepted the recommendation from the Independent Medicines and Healthcare products Regulatory Agency (MHRA) to approve Pfizer-BioNTech’s COVID-19 vaccine for use,” the government said.

“The vaccine will be made available across the UK from next week," it added,

After opening with mild gains, shares of Pfizer traded almost flat till 1230 hours but saw a sudden spike after the reports of the vaccine.

Close
The stock closed 2.44 percent higher at Rs 5,229.90 on BSE.
Moneycontrol News
first published: Dec 2, 2020 01:12 pm

stay updated

Get Daily News on your Browser
Sections